Rather than the injection of exogenously expanded and activated cDCs (DC vaccination; described below), it has been shown in pre-clinical studies that systemic injection of Flt3L leads to systemic expansion of the cDC1 population, increasing the number of these cells within B16 melanomas and significantly delaying tumor growth (10). The gene discussed is MPPE1; the disease is neoplasm.